According to our results, potential strategies to overcome the challenges posed by spatial heterogeneity, such as combination therapies or localized delivery methods, to enhance the targeting of the NEDD4L/KLF5 axis across different tumour regions. The gene discussed is NEDD4L; the disease is neoplasm.